Get started
Author

Mark K. Doherty

Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis
2017 · Gonzalo Sapisochin, Aisling Barry, et al. · Journal of Hepatology · 305
Prognostic and predictive effects of TP53 co-mutation in patients with EGFR -mutated non-small cell lung cancer (NSCLC)
2017 · Catherine Labbé, Michael Cabanero, et al. · Lung Cancer · 229
Phase II Study of External Irradiation and Weekly Paclitaxel for Nonmetastatic, Unresectable Pancreatic Cancer: RTOG-98-12
2004 · Tyvin Rich, Jonathan Harris, et al. · American Journal of Clinical Oncology · 100
LBA41 LEAP-005: Phase II study of lenvatinib (len) plus pembrolizumab (pembro) in patients (pts) with previously treated advanced solid tumours
2020 · Z. Lwin, C. Gomez-Roca, et al. · Annals of Oncology · 76
Monitoring and Management of Immune-Related Adverse Events Associated With Programmed Cell Death Protein-1 Axis Inhibitors in Lung Cancer
2016 · Grainne M. O’Kane, Catherine Labbé, et al. · The Oncologist · 74
Lenvatinib plus pembrolizumab for patients with previously treated biliary tract cancers in the multicohort phase II LEAP-005 study.
2021 · Luis Villanueva, Zarnie Lwin, et al. · Journal of Clinical Oncology · 70
Prognostic impact of marital status on survival of women with epithelial ovarian cancer
2011 · Haider Mahdi, Sanjeev Kumar, et al. · Psycho-Oncology · 59
Financial Burden Among Patients With Lung Cancer in a Publically Funded Health Care System
2018 · Doreen A. Ezeife, Brandon Josh Morganstein, et al. · Clinical Lung Cancer · 56
Treatment options for patients with brain metastases from EGFR / ALK -driven lung cancer
2017 · Mark K. Doherty, Grzegorz J. Korpanty, et al. · Radiotherapy and Oncology · 55
Severe symptoms persist for Up to one year after diagnosis of stage I-III lung cancer: An analysis of province-wide patient reported outcomes
2020 · Dhruvin H. Hirpara, Vaibhav Gupta, et al. · Lung Cancer · 40
Avelumab in unresectable/metastatic, progressive, grade 2–3 neuroendocrine neoplasms (NENs): Combined results from NET-001 and NET-002 trials
2022 · D.L. Chan, V. Rodriguez-Freixinos, et al. · European Journal of Cancer · 37
Central Nervous System Pseudoprogression in a Patient Treated with PD-1 Checkpoint Inhibitor
2015 · Mark K. Doherty, Kevin Jao, et al. · Journal of Thoracic Oncology · 37
A Case of Invasive Mucinous Pulmonary Adenocarcinoma with a CD74-NRG1 Fusion Protein Targeted with Afatinib
2017 · Parneet K. Cheema, Mark Doherty, et al. · Journal of Thoracic Oncology · 36
PDF
Real-World EQ5D Health Utility Scores for Patients With Metastatic Lung Cancer by Molecular Alteration and Response to Therapy
2016 · Catherine Labbé, Yvonne Leung, et al. · Clinical Lung Cancer · 32
Province-Wide Analysis of Patient-Reported Outcomes for Stage IV Non-Small Cell Lung Cancer
2021 · Michael C. Tjong, Mark Doherty, et al. · The Oncologist · 31
Adjuvant treatment for resected pancreatic adenocarcinoma: A systematic review and network meta-analysis
2019 · Ambica Parmar, Jorge Chaves-Porras, et al. · Critical Reviews in Oncology/Hematology · 29
Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy
2015 · Mark Doherty, Patrick Morris · International Journal of Women s Health · 29
PDF
Lenvatinib plus pembrolizumab for patients with previously treated biliary tract cancers in the multicohort phase 2 LEAP-005 study.
2021 · Luis Villanueva, Zarnie Lwin, et al. · Journal of Clinical Oncology · 27
Health utility scores from EQ-5D and health-related quality of life in patients with esophageal cancer: a real-world cross-sectional study
2018 · M K Doherty, Y Leung, et al. · Diseases of the Esophagus · 25
Long term responders to palliative chemotherapy for advanced biliary tract cancer
2017 · Mark K. Doherty, Mairéad G. McNamara, et al. · Journal of Gastrointestinal Oncology · 20
Adjuvant therapy for resected biliary tract cancer: a review
2016 · Mark K. Doherty, Jennifer J. Knox · Chinese Clinical Oncology · 20
LEAP-005: A phase 2 multicohort study of lenvatinib plus pembrolizumab in patients with previously treated selected solid tumors—Results from the colorectal cancer cohort.
2021 · Carlos A. Gomez-Roca, Eduardo Yanez, et al. · Journal of Clinical Oncology · 17
LEAP-005: A phase II multicohort study of lenvatinib plus pembrolizumab in patients with previously treated selected solid tumors—Results from the gastric cancer cohort.
2021 · Hyun Cheol Chung, Zarnie Lwin, et al. · Journal of Clinical Oncology · 17
NUC-1031/cisplatin versus gemcitabine/cisplatin in untreated locally advanced/metastatic biliary tract cancer (NuTide:121)
2020 · Mairéad Geraldine McNamara, Lipika Goyal, et al. · Future Oncology · 17
PDF
Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples
2020 · Sinead Toomey, Aoife Carr, et al. · Journal of Translational Medicine · 17
PDF
Works count: 119
Citation count: 1,786
H-index: 20
I10-index: 38
Year
Topic
Type